Patients' experiences of the implantable cardioverter defibrillator (ICD); with a focus on battery replacement and end-of-life issues.
Refusing Implantable Cardioverter Defibrillator (ICD) Replacement in Elderly Persons-The Same as Giving Up Life: A Qualitative Study.
Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database.
Efficacy and Safety of an Extravascular Implantable Cardioverter-Defibrillator.
Friedman P, Murgatroyd F, Boersma LVA, Manlucu J, O'Donnell D, Knight BP, Clémenty N, Leclercq C, Amin A, Merkely BP, Birgersdotter-Green UM, Chan JYS, Biffi M, Knops RE, Engel G, Muñoz Carvajal I, Epstein LM, Sagi V, Johansen JB, Sterliński M, Steinwender C, Hounshell T, Abben R, Thompson AE, Wiggenhorn C, Willey S, Crozier I; Extravascular ICD Pivotal Study Investigators.
N Engl J Med. 2022 Oct 6;387(14):1292-1302. doi: 10.1056/NEJMoa2206485. Epub 2022 Aug 28.
2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
Stiles MK, Fauchier L, Morillo CA, Wilkoff BL; ESC Scientific Document Group.
Europace. 2019 Sep 1;21(9):1442-1443. doi: 10.1093/europace/euz065.
Subcutaneous implantable cardioverter-defibrillator therapy in Poland: Results of the Polish S-ICD Registry.
Kempa M, Budrejko S, Tajstra M, Syska P, Lewandowski M, Fabiszak T, Michalak M, Stanek A, Nowak K, Mitkowski P, Kaczmarek K, Orski Z, Janowski M, Szafarz P, Filipecki A, Sokal A, Szołkiewicz M, Jagielski D, Przybylski A.
Kardiol Pol. 2023;81(5):455-462. doi: 10.33963/KP.a2023.0046. Epub 2023 Mar 5.
Benefit of Implantable Cardioverter-Defibrillator Generator Replacement in a Primary Prevention Population-Based Cohort.
Weng W, Sapp J, Doucette S, MacIntyre C, Gray C, Gardner M, Abdelwahab A, Parkash R.
JACC Clin Electrophysiol. 2017 Oct;3(10):1180-1189. doi: 10.1016/j.jacep.2017.03.004. Epub 2017 May 31.
Clinical performance of implantable cardioverter-defibrillator lead monitoring diagnostics.
Poole JE, Swerdlow CD, Tarakji KG, Mittal S, Ellenbogen KA, Greenspon AJ, Kennergren C, Philbert BT, Moore J, Jones RC, Schaller RD, Hansalia R, Simmers T, Mihalcz A, DeBus B, Lexcen DR, Gunderson B, Wilkoff BL.
Heart Rhythm. 2022 Mar;19(3):363-371. doi: 10.1016/j.hrthm.2021.10.032. Epub 2021 Nov 9.
Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System.
Gold MR, El-Chami MF, Burke MC, Upadhyay GA, Niebauer MJ, Prutkin JM, Herre JM, Kutalek S, Dinerman JL, Knight BP, Leigh J, Lucas L, Carter N, Brisben AJ, Aasbo JD, Weiss R; S-ICD System Post Approval Study Investigators.
J Am Coll Cardiol. 2023 Aug 1;82(5):383-397. doi: 10.1016/j.jacc.2023.05.034.
Estimating the Risks and Benefits of Implantable Cardioverter Defibrillator Generator Replacement: A Systematic Review.
Lewis KB, Stacey D, Carroll SL, Boland L, Sikora L, Birnie D.
Pacing Clin Electrophysiol. 2016 Jul;39(7):709-22. doi: 10.1111/pace.12850. Epub 2016 Apr 29.
Outcomes following implantable cardioverter-defibrillator generator replacement in adults: A systematic review.
McCarthy KJ, Locke AH, Coletti M, Young D, Merchant FM, Kramer DB.
Heart Rhythm. 2020 Jun;17(6):1036-1042. doi: 10.1016/j.hrthm.2020.01.005. Epub 2020 Jan 10.
Benefit of implantable cardioverter-defibrillator therapy after generator replacement in patients with Brugada syndrome.
Kim JY, Kim SH, Kim SS, Lee KH, Park HW, Cho JG, Uhm JS, Joung B, Pak HN, Lee MH, Park SJ, On YK, Kim JS, Lim HE, Shim J, Choi JI, Park SW, Kim YH, Lee WS, Kim J, Nam GB, Choi KJ, Kim YH, Oh YS, Lee MY, Rho TH.
Int J Cardiol. 2015;187:340-4. doi: 10.1016/j.ijcard.2015.03.262. Epub 2015 Mar 20.
Pacemaker/implantable cardioverter-defibrillator interaction.
Jimenez A, Dickfeld T, Saliaris A, Shorofsky S.
Heart Rhythm. 2010 Aug;7(8):1157-60. doi: 10.1016/j.hrthm.2010.03.045. Epub 2010 Apr 8.
